Table 5.

Summary of MTB cases and RIF-resistant cases diagnosed using the Xpert® MTB/RIF assay, by sex

		Rifampicin		Total
		Resistant	Sensitive
Sex
Male	No.	86	163	249
	%	34.5	65.5	100
Female	No.	80	265	345
	%	23.8	76.2	100
Total	No.	166	428	594
	%	27.9	72.1	100